Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BXC
BXC logo

BXC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Bluelinx Holdings Inc (BXC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
59.750
1 Day change
2.52%
52 Week Range
88.300
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Bluelinx Holdings Inc (BXC) is not a strong buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The lack of positive financial performance, weak technical indicators, and absence of significant catalysts make it prudent to hold off on investing in this stock at the current time.

Technical Analysis

The MACD is positive but contracting, suggesting weakening momentum. RSI is neutral at 54.034, indicating no clear overbought or oversold condition. Moving averages are converging, showing no strong trend. The stock is trading near its pivot level of 54.207, with resistance at 57.335 and support at 51.078.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios suggest bullish sentiment, but the overall trading volume and open interest are not significant enough to indicate strong investor activity.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
6

Positive Catalysts

  • NULL identified. No recent news or significant insider or hedge fund activity. Options data shows slight bullish sentiment, but it is not a strong driver.

Neutral/Negative Catalysts

  • The company's financial performance in Q4 2025 was poor, with net income dropping by -262.20% YoY and EPS declining by -271.43% YoY. Gross margin also decreased by -2.80% YoY. Analysts have lowered the price target from $83 to $75, signaling reduced confidence.

Financial Performance

In Q4 2025, revenue increased slightly by 0.73% YoY to $715.8M, but net income dropped significantly to -$8.55M, and EPS fell to -$1.08. Gross margin declined to 14.22%, reflecting weaker profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Benchmark has lowered the price target from $83 to $75 while maintaining a Buy rating. This indicates reduced optimism about the stock's potential upside.

Wall Street analysts forecast BXC stock price to rise
2 Analyst Rating
Wall Street analysts forecast BXC stock price to rise
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 58.280
sliders
Low
68
Averages
71.5
High
75
Current: 58.280
sliders
Low
68
Averages
71.5
High
75
Benchmark
Buy
to
Buy
downgrade
$83 -> $75
AI Analysis
2026-02-27
Reason
Benchmark
Price Target
$83 -> $75
AI Analysis
2026-02-27
downgrade
Buy
to
Buy
Reason
Benchmark lowered the firm's price target on BlueLinx to $75 from $83 and keeps a Buy rating on the shares.
DA Davidson
Neutral
downgrade
$75 -> $68
2025-11-06
Reason
DA Davidson
Price Target
$75 -> $68
2025-11-06
downgrade
Neutral
Reason
DA Davidson lowered the firm's price target on BlueLinx to $68 from $75 and keeps a Neutral rating on the shares. The company's Q3 results were highlighted by encouraging Specialty volumes growth and flat pricing, though the firm is taking a more conservative stance around the 2026 demand environment and commodity pricing assumptions, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BXC
Unlock Now

People Also Watch